BCL2L1 and urinary bladder cancer: For example, PTE treatment significantly increases autophagy-associated protein LC3-II and Bcl-xl (negative regulator of apoptosis) levels through AKT/mTOR/p70S6K axis regulation in T24 human bladder cancer cells [13].